Effects of liposomal calcium on absorption and metabolism
Effects of Liposomal Encapsulation on Calcium Powder Absorption and Metabolism
This study is testing if a new type of calcium supplement that uses liposomal technology helps adults absorb calcium better and have fewer stomach issues compared to regular calcium pills.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | All |
| Sponsor | National Yang Ming Chiao Tung University Academic / other |
| Locations | 2 sites (Taipei, Beitou Dist. and 1 other locations) |
| Trial ID | NCT06372158 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of liposomal encapsulation on the absorption and metabolism of calcium powder compared to traditional calcium supplements. By utilizing liposomal technology, the study aims to enhance the bioavailability of calcium, allowing for a slower release in the intestines and minimizing gastrointestinal side effects. Participants will take liposomal calcium orally, which does not require dissolution in water, making it a more convenient option for long-term use. The study targets adults aged 20-60 who meet specific health criteria to assess the efficacy of this innovative calcium supplement.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 20-60 without major organ diseases who can fully cooperate with the experiment.
Not a fit: Patients with renal insufficiency, cancer, or those on chronic disease medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a more effective and convenient calcium supplement option for individuals at risk of osteoporosis.
How similar studies have performed: While the use of liposomal technology in supplements is promising, this specific approach to calcium absorption is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 20-60 years old, without heart, liver, kidney, endocrine or major organic diseases (patient report), and able to fully cooperate with the experiment. Exclusion Criteria: 1. Patients with renal insufficiency and dialysis 2. Cancer patients 3. Underweight (BMI#17) or obese (BMI#27) 4. Those taking medications for chronic diseases 5. Blood pressure systolic blood pressure # 130 mmHg or diastolic blood pressure # 85 mmHg 6. Fasting blood glucose # 100 mg/dL 7. Fasting triglycerides # 150 mg/dL, total cholesterol # 200 mg/dL 8. Have a history of vitamin C allergy 9. People suffering from mental illness 10. Pregnant and breastfeeding women 11. Patients with hemosiderosis 12. Kidney stone patients 13. Supplements for those who take calcium for a long time
Where this trial is running
Taipei, Beitou Dist. and 1 other locations
- National Yang Ming Chiao Tung University — Taipei, Beitou Dist., Taiwan (Recruiting)
- National Yang Ming Chiao Tung University — Taipei, Taiwan (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.